Patents by Inventor Gary T. Wang

Gary T. Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • (S)-abscisic acid derivatives for thinning
    Patent number: 9872492
    Abstract: The present invention is directed to the treatment of apple trees, peach trees, and grape vines with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to reduce the number of fruits on the trees or vines that grow to maturity.
    Type: Grant
    Filed: May 19, 2016
    Date of Patent: January 23, 2018
    Assignee: Valent Biosciences LLC
    Inventors: Derek D. Woolard, Gary T. Wang, Daniel C. Leep, Gregory D. Venburg
  • 3?-SUBSTITUTED-ABSCISIC ACID DERIVATIVES
    Publication number: 20170360037
    Abstract: The invention relates to a novel class of (S)-3?-substituted-abscisic acid derivatives and (±)-3?-substituted-abscisic acid derivatives, and methods of synthesizing the derivatives.
    Type: Application
    Filed: September 5, 2017
    Publication date: December 21, 2017
    Inventors: Gary T. Wang, Daniel F. Heiman, Gregory D. Venburg, Eiki Nagano, Marci Surpin, Joseph H. Lustig
  • 3?-substituted-abscisic acid derivatives
    Patent number: 9781930
    Abstract: The invention relates to a novel class of (S)-3?-substituted-abscisic acid derivatives and (±)-3?-substituted-abscisic acid derivatives, and methods of synthesizing the derivatives.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: October 10, 2017
    Assignee: Valent BioSciences LLC
    Inventors: Gary T. Wang, Daniel Heiman, Gregory D. Venburg, Eiki Nagano, Marci Surpin, Joseph H. Lustig
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20170158666
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: July 25, 2016
    Publication date: June 8, 2017
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • (S)-ABSCISIC ACID DERIVATIVES FOR IMPROVING PLANT STRESS TOLERANCE
    Publication number: 20160338353
    Abstract: The present invention is directed to the treatment of crop plants with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to improve the plants' environmental stress tolerance.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 24, 2016
    Inventors: Franklin Paul Silverman, Gary T. Wang, Kimberly Ann Falco, Derek D. Woolard, Dale O. Wilson, JR., Daniel C. Leep, Gregory D. Venburg
  • (S)-ABSCISIC ACID DERIVATIVES FOR ENHANCED GRAPE COLORATION
    Publication number: 20160338351
    Abstract: The present invention is directed to the treatment of grapes with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to enhance the color of the grapes.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 24, 2016
    Inventors: Derek D. Woolard, Gary T. Wang, Rick Hopkins, Daniel C. Leep, Gregory D. Venburg
  • (S)-ABSCISIC ACID DERIVATIVES FOR THINNING
    Publication number: 20160338352
    Abstract: The present invention is directed to the treatment of apple trees, peach trees, and grape vines with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to reduce the number of fruits on the trees or vines that grow to maturity.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 24, 2016
    Inventors: Derek D. Woolard, Gary T. Wang, Daniel C. Leep, Gregory D. Venburg
  • (S)-ABSCISIC ACID DERIVATIVES FOR ENHANCED FRUIT AND VEGETABLE COLORATION
    Publication number: 20160338354
    Abstract: The present invention is directed to the treatment of fruits and vegetables with 3?-methyl-(S)-abscisic acid, 3?-propargyl-(S)-abscisic acid, and/or salts thereof in order to enhance the color of the fruits and vegetables.
    Type: Application
    Filed: May 19, 2016
    Publication date: November 24, 2016
    Inventors: Derek D. Woolard, Gary T. Wang, Rick Hopkins, Daniel C. Leep, Gregory D. Venburg
  • APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20160304451
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: February 19, 2016
    Publication date: October 20, 2016
    Inventors: Steven W. Elmore, Aaron R. Kunzer, Robert A. Mantei, Andrew J. Souers, Gerard M. Sullivan, Gary T. Wang, Le Wang, Michael D. Wendt
  • ()-2?-vinyl-abscisic acid derivatives
    Patent number: 9447015
    Abstract: The invention relates to a novel class of (S)-2?-vinyl-substituted-abscisic acid derivatives, and to methods of synthesizing and using the derivatives.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: September 20, 2016
    Assignee: Valent BioSciences Corporation
    Inventors: Gary T. Wang, Daniel F. Heiman, Gregory D. Venburg, Joseph Lustig, Marci Ann Surpin, Robert Erwin Fritts, Jr., Franklin Paul Silverman, Derek D. Woolard
  • Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
    Patent number: 9303025
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: April 5, 2016
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura Hexamer, Aaron R. Kunzer, Robert A. Mantei, Cheol-Min Park, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • 3'-SUBSTITUTED-ABSCISIC ACID DERIVATIVES
    Publication number: 20160007598
    Abstract: The invention relates to a novel class of (S)-3?-substituted-abscisic acid derivatives and (±)-3?-substituted-abscisic acid derivatives, and methods of synthesizing the derivatives.
    Type: Application
    Filed: July 8, 2015
    Publication date: January 14, 2016
    Inventors: Gary T. Wang, Daniel Heiman, Gregory D. Venburg, Eiki Nagano, Marci Surpin, Joseph H. Lustig
  • APOPTOSIS-INDUCING AGENT FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20160002187
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: September 15, 2015
    Publication date: January 7, 2016
    Inventors: Aaron R. Kunzer, Steven W. Elmore, Laura A. Hexamer, Cheol-Min Park, Andrew J. Souers, Gerard M. Sullivan, Gary T. Wang, Xilu Wang, Michael D. Wendt
  • APOPTOSIS INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20150329541
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: April 23, 2015
    Publication date: November 19, 2015
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert Mantei, Todd M. Hansen
  • Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
    Patent number: 9174982
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: November 3, 2015
    Assignees: ABBVIE INC., GENENTECH, INC., THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa A. Hasvold, Laura Hexamer, Aaron R. Kunzer, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Robert A. Mantei, Todd M. Hansen
  • Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
    Patent number: 9156856
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: October 13, 2015
    Assignee: AbbVie Inc.
    Inventors: Aaron R. Kunzer, Steven W. Elmore, Laura A. Hexamer, Cheol-Min Park, Andrew J. Souers, Gerard M Sullivan, Gary T. Wang, Xilu Wang, Michael D. Wendt
  • Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
    Patent number: 9125913
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: September 8, 2015
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, Robert A. Mantei, William J. McClellan, Chang H. Park, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
    Patent number: 9073855
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: July 7, 2015
    Assignee: ABBVIE INC.
    Inventors: George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura Hexamer, Robert A. Mantei, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt, Todd M. Hansen
  • BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
    Patent number: 9072748
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.
    Type: Grant
    Filed: October 18, 2013
    Date of Patent: July 7, 2015
    Assignee: AbbVie Inc.
    Inventors: Milan Bruncko, Hong Ding, George A. Doherty, Steven W. Elmore, Lisa Hasvold, Laura A. Hexamer, Aaron R. Kunzer, Robert A. Mantei, William J. McClellan, Chang H. Park, Cheol-Min Park, Andrew M. Petros, Xiaohong Song, Andrew J. Souers, Gerard M. Sullivan, Zhi-Fu Tao, Gary T. Wang, Le Wang, Xilu Wang, Michael D. Wendt
  • APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
    Publication number: 20150183775
    Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
    Type: Application
    Filed: December 23, 2014
    Publication date: July 2, 2015
    Inventors: Milan BRUNCKO, Yujia DAI, Hong DING, George A. DOHERTY, Steven W. ELMORE, Lisa HASVOLD, Laura HEXAMER, Aaron R. KUNZER, Robert A. MANTEI, Chang H. PARK, Cheol-Min PARK, Andrew M. PETROS, Xiaohong SONG, Andrew J. SOUERS, Gerard M. SULLIVAN, Zhi-Fu TAO, Gary T. WANG, Le WANG, Xilu WANG, Michael D. WENDT, William J. MCCLELLAN